Abstract
Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal complication of the use of certain medications. It is being seen more often in the pediatric population because of the increasing use of both typical and atypical antipsychotics in children. Rapid recognition of NMS is important to emergency physicians because timely treatment can be life saving. Acute dystonia is also a well-known and more common adverse effect of certain types of antipsychotics, more commonly seen with the typical antipsychotics versus the atypical antipsychotics. We describe a case of a pediatric patient who developed an acute dystonic reaction versus NMS soon after starting aripiprazole. We compare this case with the other documented cases of acute dystonia and NMS after initiating aripiprazole in the pediatric population.
Original language | English (US) |
---|---|
Pages (from-to) | 38-40 |
Number of pages | 3 |
Journal | Pediatric Emergency Care |
Volume | 33 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2017 |
All Science Journal Classification (ASJC) codes
- Pediatrics, Perinatology, and Child Health
- Emergency Medicine